+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Aerosol Drug Delivery Devices Market Size, Share & Trends Analysis Report by Type (Inhaler, Nebulizer), Application (COPD, Asthma, Cystic Fibrosis), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 6056096
Description Jump to:
The Aerosol Drug Delivery Devices Market was valued at USD 29.8 billion in 2024, and is projected to reach USD 62.1 billion by 2030, rising at a CAGR of 13.16%. The market is expected to expand at a notable CAGR of 13.16% from 2025 to 2030. Major factors driving the market growth include the rising prevalence of respiratory diseases, increasing healthcare awareness, advancements in inhaler technology, and the growing demand for home-based treatments.

The market growth is driven by the increasing prevalence of respiratory diseases such as COPD, asthma, and cystic fibrosis, a growing focus on portable inhalation devices, and the need for quick, effective treatments. Other factors include government awareness campaigns, an aging population, technological advancements, higher device adoption, urbanization, pollution, and increased R&D.

Innovation in the market focuses on developing eco-friendly fuels, improving user-interface designs for better patient adherence, and using AI for personalized diagnostics and treatment. Research into biodegradable materials could provide sustainable alternatives for device construction. The market is competitive and fragmented, with rapid technological progress driving constant change. Companies proactively embrace trends, focusing on patient-centered, environmentally friendly solutions to seize growth opportunities.

Moreover, key players in the market, such as AptarGroup, Inc., Koninklijke Philips N.V., AstraZeneca, and Novartis AG, among others, are engaging in strategic initiatives such as partnerships, collaborations, new product launches, acquisitions, and expansions to strengthen their market position. For instance, in January 2024, Kindeva Drug Delivery announced the acquisition of Summit Biosciences, a company specializing in intranasal drug delivery.

“Nasal drug delivery is becoming a preferred dosage format for a growing number of indications, as it allows users to non-invasively administer medications in an acute or emergency setting. Summit brings a differentiated understanding of how to effectively formulate drugs for nasal delivery and the capability to manufacture them at commercial scale. This addition not only fits Kindeva’s ambition to be a global leader in the drug-device combination products CDMO market but also expands the toolbox we can offer our customers to help improve patient outcomes and experience of care globally.”
  • Kindeva CEO Milton Boyer.

Aerosol Drug Delivery Devices Market Report Highlights

  • Based on type, the inhaler segment dominated the market with a revenue share of 89.59% in 2024 and is expected to witness the fastest growth at a CAGR over the forecast period owing to the advancement the development of technologically advanced products, and the growing adoption of digital solutions in the healthcare sector.
  • Based on application, the COPD segment held the largest market share in 2024 and is anticipated to be the fastest-growing segment over the forecast period owing to the rising increasing prevalence worldwide.
  • Based on the distribution channel, the institutional pharmacies segment held the largest market share in 2024, driven by the increasing need for bulk medication distribution, and the expanding patient population with respiratory conditions.
  • North America dominated the aerosol drug delivery devices industry with a market share of 39.49% in 2024, owing to the advanced healthcare infrastructure, increasing geriatric population, and technological advancements.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.5. Details of primary research
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.1.2. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type Outlook
2.2.2. Application Outlook
2.2.3. Distribution Channel Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Aerosol Drug Delivery Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Industry Analysis
3.2.1. User Perspective Analysis
3.2.2. Key End Users
3.3. Technology Outlook
3.4. Regulatory Framework
3.5. Market Dynamics
3.5.1. Market Drivers Analysis
3.5.1.1. Rising prevalence of respiratory diseases
3.5.1.2. Technological advancements
3.5.1.3. Rising geriatric population
3.5.1.4. Increasing awareness of self-medication and home healthcare
3.5.2. Market Restraints Analysis
3.5.2.1. High cost of devices
3.5.3. Industry Challenges and Opportunity Analysis
3.6. Aerosol Drug Delivery Devices Market Analysis Tools
3.6.1. Porter’s Analysis
3.6.1.1. Bargaining power of the suppliers
3.6.1.2. Bargaining power of the buyers
3.6.1.3. Threats of substitution
3.6.1.4. Threats from new entrants
3.6.1.5. Competitive rivalry
3.6.2. PESTEL Analysis
3.6.2.1. Political landscape
3.6.2.2. Economic and Social landscape
3.6.2.3. Technological landscape
3.6.2.4. Environmental landscape
3.6.2.5. Legal Landscape
3.7. Impact of COVID-19
Chapter 4. Aerosol Drug Delivery Devices Market: Type Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Aerosol Drug Delivery Devices Market: By Type, 2018 to 2030
4.4.1. Nebulizers
4.4.1.1. Nebulizers Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.1.2. Jet
4.4.1.2.1. Jet Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.1.3. Mesh
4.4.1.3.1. Mesh Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.1.4. Active
4.4.1.4.1. Active Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.1.5. Passive
4.4.1.5.1. Passive Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.1.6. Ultrasonic
4.4.1.6.1. Ultrasonic Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.2. Inhaler
4.4.2.1. Inhaler Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.2.2. Pressurized Metered-Dose Inhaler (PMDI)
4.4.2.2.1. Pressurized Metered-Dose Inhaler (PMDI) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.2.3. Dry-Powder Inhaler (DPI)
4.4.2.3.1. Dry-Powder Inhaler (DPI) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. Aerosol Drug Delivery Devices Market: Application Estimates & Trend Analysis
5.1. Definition and Scope
5.2. Application Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Aerosol Drug Delivery Devices Market: By Application, 2018 to 2030
5.4.1. Asthma
5.4.1.1. Asthma Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.2. Chronic Obstructive Pulmonary Disease (COPD)
5.4.2.1. Chronic Obstructive Pulmonary Disease (COPD) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. Aerosol Drug Delivery Devices Market: Distribution Channel Estimates & Trend Analysis
6.1. Definition and Scope
6.2. Distribution Channel Market Share Analysis, 2024 & 2030
6.3. Segment Dashboard
6.4. Aerosol Drug Delivery Devices Market: By Distribution Channel, 2018 to 2030
6.4.1. Retail Pharmacies
6.4.1.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.4.2. Institutional Pharmacies
6.4.2.1. Institutional Pharmacies Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.4.3. Online Pharmacies
6.4.3.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. Aerosol Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Region, Type, Application, Distribution Channel
7.1. Definition and Scope
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot
7.5. SWOT Analysis
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. Aerosol Drug Delivery Devices Market Share, by Region, 2024 & 2030, USD Million
7.7. North America
7.7.1. North America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.2. U.S.
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory Landscape/Reimbursement Scenario
7.7.2.3. Competitive Insights
7.7.2.4. U.S. Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.3. Canada
7.7.3.1. Key Country Dynamics
7.7.3.2. Regulatory Landscape/Reimbursement Scenario
7.7.3.3. Competitive Insights
7.7.3.4. Canada Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7.4. Mexico
7.7.4.1. Key Country Dynamics
7.7.4.2. Regulatory Landscape/Reimbursement Scenario
7.7.4.3. Competitive Insights
7.7.4.4. Canada Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8. Europe
7.8.1. Europe Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.2. UK
7.8.2.1. Key Country Dynamics
7.8.2.2. Regulatory Landscape/Reimbursement Scenario
7.8.2.3. Competitive Insights
7.8.2.4. UK Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.3. Germany
7.8.3.1. Key Country Dynamics
7.8.3.2. Regulatory Landscape/Reimbursement Scenario
7.8.3.3. Competitive Insights
7.8.3.4. Germany Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.4. France
7.8.4.1. Key Country Dynamics
7.8.4.2. Regulatory Landscape/Reimbursement Scenario
7.8.4.3. Competitive Insights
7.8.4.4. France Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.5. Italy
7.8.5.1. Key Country Dynamics
7.8.5.2. Regulatory Landscape/Reimbursement Scenario
7.8.5.3. Competitive Insights
7.8.5.4. Italy Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.6. Spain
7.8.6.1. Key Country Dynamics
7.8.6.2. Regulatory Landscape/Reimbursement Scenario
7.8.6.3. Competitive Insights
7.8.6.4. Spain Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.7. Sweden
7.8.7.1. Key Country Dynamics
7.8.7.2. Regulatory Landscape/Reimbursement Scenario
7.8.7.3. Competitive Insights
7.8.7.4. Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.8. Denmark
7.8.8.1. Key Country Dynamics
7.8.8.2. Regulatory Landscape/Reimbursement Scenario
7.8.8.3. Competitive Insights
7.8.8.4. Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8.9. Norway
7.8.9.1. Key Country Dynamics
7.8.9.2. Regulatory Landscape/Reimbursement Scenario
7.8.9.3. Competitive Insights
7.8.9.4. Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.9. Asia Pacific
7.9.1. Asia Pacific Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.9.2. China
7.9.2.1. Key Country Dynamics
7.9.2.2. Regulatory Landscape/Reimbursement Scenario
7.9.2.3. Competitive Insights
7.9.2.4. China Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.9.3. Japan
7.9.3.1. Key Country Dynamics
7.9.3.2. Regulatory Landscape/Reimbursement Scenario
7.9.3.3. Competitive Insights
7.9.3.4. Japan Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.9.4. India
7.9.4.1. Key Country Dynamics
7.9.4.2. Regulatory Landscape/Reimbursement Scenario
7.9.4.3. Competitive Insights
7.9.4.4. India Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.9.5. South Korea
7.9.5.1. Key Country Dynamics
7.9.5.2. Regulatory Landscape/Reimbursement Scenario
7.9.5.3. Competitive Insights
7.9.5.4. South Korea Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.9.6. Australia
7.9.6.1. Key Country Dynamics
7.9.6.2. Regulatory Landscape/Reimbursement Scenario
7.9.6.3. Competitive Insights
7.9.6.4. Australia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.9.7. Thailand
7.9.7.1. Key Country Dynamics
7.9.7.2. Regulatory Landscape/Reimbursement Scenario
7.9.7.3. Competitive Insights
7.9.7.4. Thailand Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.10. Latin America
7.10.1. Latin America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.10.2. Brazil
7.10.2.1. Key Country Dynamics
7.10.2.2. Regulatory Landscape/Reimbursement Scenario
7.10.2.3. Competitive Insights
7.10.2.4. Brazil Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.10.3. Argentina
7.10.3.1. Key Country Dynamics
7.10.3.2. Regulatory Landscape/Reimbursement Scenario
7.10.3.3. Competitive Insights
7.10.3.4. Argentina Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.11. Middle East and Africa
7.11.1. Middle East and Africa Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.11.2. South Africa
7.11.2.1. Key Country Dynamics
7.11.2.2. Regulatory Landscape/Reimbursement Scenario
7.11.2.3. Competitive Insights
7.11.2.4. South Africa Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.11.3. Saudi Arabia
7.11.3.1. Key Country Dynamics
7.11.3.2. Regulatory Landscape/Reimbursement Scenario
7.11.3.3. Competitive Insights
7.11.3.4. Saudi Arabia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.11.4. UAE
7.11.4.1. Key Country Dynamics
7.11.4.2. Regulatory Landscape/Reimbursement Scenario
7.11.4.3. Competitive Insights
7.11.4.4. UAE Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
7.11.5. Kuwait
7.11.5.1. Key Country Dynamics
7.11.5.2. Regulatory Landscape/Reimbursement Scenario
7.11.5.3. Competitive Insights
7.11.5.4. UAE Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Market Share Analysis
8.4. Company Heat Map Analysis
8.5. Strategy Mapping
8.5.1. Expansion
8.5.2. Mergers & Acquisition
8.5.3. Partnerships & Collaborations
8.5.4. New Product Launches
8.5.5. Research And Development
8.6. Company Profiles
8.6.1. AptarGroup, Inc.
8.6.1.1. Participant’s Overview
8.6.1.2. Financial Performance
8.6.1.3. Product Benchmarking
8.6.1.4. Recent Developments
8.6.2. Koninklijke Philips N.V.
8.6.2.1. Participant’s Overview
8.6.2.2. Financial Performance
8.6.2.3. Product Benchmarking
8.6.2.4. Recent Developments
8.6.3. AstraZeneca
8.6.3.1. Participant’s Overview
8.6.3.2. Financial Performance
8.6.3.3. Product Benchmarking
8.6.3.4. Recent Developments
8.6.4. Novartis AG
8.6.4.1. Participant’s Overview
8.6.4.2. Financial Performance
8.6.4.3. Product Benchmarking
8.6.4.4. Recent Developments
8.6.5. Sanofi
8.6.5.1. Participant’s Overview
8.6.5.2. Financial Performance
8.6.5.3. Product Benchmarking
8.6.5.4. Recent Developments
8.6.6. OMRON Corporation
8.6.6.1. Participant’s Overview
8.6.6.2. Financial Performance
8.6.6.3. Product Benchmarking
8.6.6.4. Recent Developments
8.6.7. Medline Industries, LP.
8.6.7.1. Participant’s Overview
8.6.7.2. Financial Performance
8.6.7.3. Product Benchmarking
8.6.7.4. Recent Developments
8.6.8. GF Health Products, Inc.
8.6.8.1. Participant’s Overview
8.6.8.2. Financial Performance
8.6.8.3. Product Benchmarking
8.6.8.4. Recent Developments
8.6.9. DRIVE MEDICAL GMBH & CO. KG
8.6.9.1. Participant’s Overview
8.6.9.2. Financial Performance
8.6.9.3. Product Benchmarking
8.6.9.4. Recent Developments
8.6.10. Teva Pharmaceutical Industries Ltd
8.6.10.1. Participant’s Overview
8.6.10.2. Financial Performance
8.6.10.3. Product Benchmarking
8.6.10.4. Recent Developments
8.6.11. Aerogen (Stamford Devices Limited Group)
8.6.11.1. Participant’s Overview
8.6.11.2. Financial Performance
8.6.11.3. Product Benchmarking
8.6.11.4. Recent Developments
8.6.12. Sensirion AG
8.6.12.1. Participant’s Overview
8.6.12.2. Financial Performance
8.6.12.3. Product Benchmarking
8.6.12.4. Recent Developments
8.6.13. PARI Respiratory Equipment, Inc.
8.6.13.1. Participant’s Overview
8.6.13.2. Financial Performance
8.6.13.3. Product Benchmarking
8.6.13.4. Recent Developments
8.6.14. Catalent, Inc
8.6.14.1. Participant’s Overview
8.6.14.2. Financial Performance
8.6.14.3. Product Benchmarking
8.6.14.4. Recent Developments
8.6.15. Pfizer Inc.
8.6.15.1. Participant’s Overview
8.6.15.2. Financial Performance
8.6.15.3. Product Benchmarking
8.6.15.4. Recent Developments
8.6.16. Beurer GmbH
8.6.16.1. Participant’s Overview
8.6.16.2. Financial Performance
8.6.16.3. Product Benchmarking
8.6.16.4. Recent Developments
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 4 North America aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 5 North America aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 6 U.S. aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 7 U.S. aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 8 U.S. aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 9 Canada aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 10 Canada aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 11 Canada aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 12 Mexico aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 13 Mexico aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 14 Mexico aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 15 Europe aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 16 Europe aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 17 Europe aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 18 UK aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 19 UK aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 20 UK aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 21 Germany aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 22 Germany aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 23 Germany aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 24 France aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 25 France aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 26 France aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 27 Italy aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 28 Italy aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 29 Italy aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 30 Spain aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 31 Spain aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 32 Spain aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 33 Sweden aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 34 Sweden aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 35 Sweden aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 36 Denmark aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 37 Denmark aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 38 Denmark aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 39 Norway aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 40 Norway aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 41 Norway aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 42 Asia Pacific aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 43 Asia Pacific aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 44 Asia Pacific aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 45 Japan aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 46 Japan aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 47 Japan aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 48 China aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 49 China aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 50 China aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 51 India aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 52 India aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 53 India aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 54 Australia aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 55 Australia aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 56 Australia aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 57 South Korea aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 58 South Korea aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 59 Thailand aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 60 Thailand aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 61 Thailand aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 62 Latin America aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 63 Latin America aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 64 Latin America aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 65 Brazil aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 66 Brazil aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 67 Brazil aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 68 Argentina aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 69 Argentina aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 70 Argentina aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 71 MEA aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 72 MEA aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 73 MEA aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 74 South Africa aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 75 South Africa aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 76 South Africa aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 77 Saudi Arabia aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 78 Saudi Arabia aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 79 Saudi Arabia aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 80 UAE aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 81 UAE aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 82 UAE aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
Table 83 Kuwait aerosol drug delivery devices market estimates and forecasts, by type, 2018-2030 (USD Million)
Table 84 Kuwait aerosol drug delivery devices market estimates and forecasts, by application, 2018-2030 (USD Million)
Table 85 Kuwait aerosol drug delivery devices market estimates and forecasts by distribution channel, 2018-2030 (USD Million)
List of Figures
Figure 1 List of Figures
Figure 2 Aerosol Drug Delivery Devices Market Segmentation
Figure 3 Information Procurement
Figure 4 Data Analysis Models
Figure 5 Market Formulation and Validation
Figure 6 Data Validating & Publishing
Figure 7 Market Snapshot
Figure 8 Segment Snapshot (1/2)
Figure 9 Segment Snapshot (2/2)
Figure 10 Competitive Landscape Snapshot
Figure 11 Aerosol Drug Delivery Devices- Market Size and Growth Prospects (USD Million)
Figure 12 Aerosol Drug Delivery Devices Market: Industry Value Chain Analysis
Figure 13 Aerosol Drug Delivery Devices Market: Market Dynamics
Figure 14 Aerosol Drug Delivery Devices Market: PORTER’s Analysis
Figure 15 Aerosol Drug Delivery Devices Market: PESTEL Analysis
Figure 16 Aerosol Drug Delivery Devices Market: Type movement analysis, 2018-2030 (USD Million)
Figure 17 Aerosol Drug Delivery Devices Market Share Analysis by Type, 2024 & 2030
Figure 18 Nebulizers Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 19 Jet Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 20 Mesh Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 21 Active Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 22 Passive Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 23 Ultrasonic Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 24 Inhaler Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 25 Pressurized Metered-Dose Inhaler (PDMI) Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 26 Dry-Powder Inhaler (DPI) Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 27 Aerosol Drug Delivery Devices Market: Application movement analysis, 2018-2030 (USD Million)
Figure 28 Aerosol Drug Delivery Devices Market Share Analysis by Application , 2024 & 2030
Figure 29 Asthma Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 30 Chronic Obstructive Pulmonary Disease (COPD) Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 31 Cystic Fibrosis Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 32 Other (Pulmonary Arterial Hypertension (PAH), etc.) Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 33 Aerosol Drug Delivery Devices Market: Distribution Channel Movement Analysis, 2018-2030 (USD Million)
Figure 34 Aerosol Drug Delivery Devices Market Share Analysis by Distribution Channel, 2024 & 2030
Figure 35 Retail Pharmacies Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 36 Institutional Pharmacies Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 37 Online Pharmacies Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 38 Aerosol Drug Delivery Devices Market Revenue, by Region, 2024 & 2030, (USD Million)
Figure 39 Regional Marketplace: Key Takeaways
Figure 40 North America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 U.S. Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Canada Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 Mexico Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Europe Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 UK Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030,) (USD Million)
Figure 46 Germany Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
Figure 47 France Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
Figure 48 Italy Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
Figure 49 Spain Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
Figure 50 Sweden Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
Figure 51 Denmark Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
Figure 52 Norway Aerosol Drug Delivery Devices Market Estimates and Forecasts, (2018 - 2030,) (USD Million)
Figure 53 Asia Pacific Aerosol Drug Delivery Devices Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 54 Japan Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 China Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 56 India Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Australia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 58 Thailand Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Latin America Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 60 Brazil Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 61 Argentina Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 62 MEA Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 63 Saudi Arabia Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 UAE Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 65 South Africa Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 66 Kuwait Aerosol Drug Delivery Devices Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 67 Key Company Categorization
Figure 68 Company Market Positioning
Figure 69 Key Company Market Share Analysis, 2024
Figure 70 Strategic Framework

Companies Mentioned

The major companies profiled in this Aerosol Drug Delivery Devices market report include:
  • AptarGroup, Inc.
  • Koninklijke Philips N.V.
  • AstraZeneca
  • Novartis AG
  • Sanofi
  • OMRON Corporation
  • Medline Industries, LP.
  • GF Health Products, Inc.
  • DRIVE MEDICAL GMBH & CO. KG
  • Teva Pharmaceutical Industries Ltd
  • Aerogen (Stamford Devices Limited Group)
  • Sensirion AG
  • PARI Respiratory Equipment, Inc.
  • Catalent, Inc
  • Pfizer Inc.
  • Beurer GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 29.8 Billion
Forecasted Market Value ( USD ) by 2030 $ 62.1 Billion
Compound Annual Growth Rate13.1%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Respiratory Drug Delivery Market Report 2024-2034 - Product Image

Respiratory Drug Delivery Market Report 2024-2034

  • Report
  • 348 Pages
  • Global
From
Drug Device Combination Products - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Drug Device Combination Products - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 125 Pages
  • Global
From
Pulmonary / Respiratory Drug Delivery - Global Strategic Business Report - Product Image

Pulmonary / Respiratory Drug Delivery - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Pulmonary Drug Delivery Systems Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Indication, Distribution Channel, End User, and Geography - Product Image

Pulmonary Drug Delivery Systems Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Indication, Distribution Channel, End User, and Geography

  • Report
  • 150 Pages
  • Global
From
Drug Delivery System Industry Forecasts - China Focus - Product Image

Drug Delivery System Industry Forecasts - China Focus

  • Report
  • 104 Pages
  • China
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.